{"id":69086,"date":"2022-09-20T13:38:13","date_gmt":"2022-09-20T11:38:13","guid":{"rendered":"https:\/\/packaging-journal.de\/?p=69086"},"modified":"2022-09-19T13:43:47","modified_gmt":"2022-09-19T11:43:47","slug":"safety-concepts-anti-counterfeiting-solutions-pharmaceutical-packaging","status":"publish","type":"post","link":"https:\/\/packaging-journal.de\/en\/sicherheitskonzepte-faelschungsschutzloesungen-pharmaverpackungen\/","title":{"rendered":"Security concepts and anti-counterfeiting solutions for pharmaceutical packaging"},"content":{"rendered":"
\"\"<\/a><\/div><\/div>\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Customised security concepts and labels for pharmaceutical packaging can help to curb problems with counterfeit, harmful or tampered medicines. Various solutions designed by pharmaceutical labelling specialist Schreiner MediPharm also make an important and effective contribution here.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

For years, the pharmaceutical industry has been facing the Growing threat from counterfeit medicines<\/strong> exposed. This now not only affects developing countries and emerging markets, but has also become a global challenge. The risk of grey market activities and illegal reuse of original containers is also increasing. These counterfeit medicines can result not only in brand and image damage for pharmaceutical companies, but also in considerable economic losses. In addition, more and more regulatory requirements that require special solutions for product and brand protection and for tracking the supply chain.<\/strong> require.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Individual security concepts minimise counterfeiting potential<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The introduction of the EU Falsified Medicines Directive in February 2019 was the first legal, Europe-wide measure to prevent the threatening development of counterfeit medicines. However, the directive does not take into account the primary packaging, but only the outer packaging of the medicine and also Characteristics for verifying originality are not prescribed, but are at the discretion of the pharmaceutical manufacturer<\/strong>. However, these play a major role in meeting all possible threat scenarios. The core issue is therefore Integrity and security of the entire pharmaceutical supply chain<\/strong>.<\/p>

\"\"<\/a><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The first step in developing an effective safety concept is to determine the situation, for example what threat the medicinal product is exposed to and who will be involved in the verification process. If the threat lies in the exchange of medicinal products Security labels with first-opening indication that irreversibly indicate a tampering attempt and ensure the integrity of the packaging<\/strong>. Security labels with integrated overt, covert and digital anti-counterfeiting features are the ideal solution for checking the authenticity of counterfeit medicines. If the problem is illegal diversion, then Security labels with RFID\/NFC and track & trace solutions for digital identification and online verification<\/strong> help to prevent the scenario. After analysing the requirements profile, pharmaceutical security experts work with the pharmaceutical manufacturer to define the individual security concept.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Security features protect primary and secondary packaging<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In general, every safety concept must be tailored to the respective packaging format such as folding box, syringe or vial. The most effective are Concepts that combine different security features<\/strong> and can be supplemented with additional functions. This results in effective, multi-level security solutions for tamper evidence and first-opening indication, counterfeit protection and proof of authenticity as well as identification and traceability.<\/p>